[Modification or stopping of the initial antiretroviral combination therapy with protease-inhibitors: incidence and reasons].
E N
EN
van Roon
A C
AC
Egberts
J M
JM
Verzijl
A W
AW
Lenderink
M
M
Blans
J R
JR
Juttmann
D000998:Antiviral Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count / Q000187:drug effects; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010349:Patient Compliance; D012307:Risk Factors; D019562:Viral Load
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors